A small proof-of -concept study of Varoglutamstat in orphan kidney disorders
Latest Information Update: 20 Jan 2025
Price :
$35 *
At a glance
- Drugs Varoglutamstat (Primary)
- Indications Kidney disorders
- Focus Adverse reactions; Proof of concept
- 20 Jan 2025 New trial record
- 14 Jan 2025 According to a Vivoryon Therapeutics media release, initiation of future studies along with this study is subject to additional funding and/or partnership, which Vivoryon will continue to actively explore.